Status and phase
Conditions
Treatments
About
To study the efficacy and safety of finerenone vs. spironolactone in patients with primary aldosteronism
Full description
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
150 participants in 2 patient groups
Loading...
Central trial contact
Yuanyuan Kang, MD. PhD; Jiguang Wang, MD. PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal